Verona Pharma plc
VRNA
$63.32
-$2.94-4.44%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 0.41% | 18.96% | -16.94% | 58.74% | -6.21% |
| Total Receivables | 82.76% | 198.28% | 239.06% | -67.86% | 4.63% |
| Inventory | 15.92% | 44.82% | -- | -- | -- |
| Prepaid Expenses | 49.44% | -4.91% | 46.59% | 50.00% | 0.14% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 373.67% | -20.56% | 33.66% | 37.39% | -44.28% |
| Total Current Assets | 10.46% | 24.52% | -12.50% | 53.14% | -6.17% |
|
|
|||||
| Total Current Assets | 10.46% | 24.52% | -12.50% | 53.14% | -6.17% |
| Net Property, Plant & Equipment | -9.36% | 56.09% | -11.64% | -9.54% | -11.98% |
| Long-term Investments | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Goodwill | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 230.02% | -- | -- | -- | -- |
| Total Assets | 10.90% | 24.21% | -12.05% | 49.74% | -5.91% |
|
|
|||||
| Total Accounts Payable | -19.43% | 64.92% | 64.52% | -10.73% | 33.19% |
| Total Accrued Expenses | 106.20% | -2.48% | -6.71% | 137.39% | 130.66% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -40.34% | 89.81% | -7.66% | -7.78% | -5.25% |
| Total Finance Division Other Current Liabilities | -18.59% | 533.48% | -92.12% | 3,097.42% | 69.20% |
| Total Other Current Liabilities | -18.59% | 533.48% | -92.12% | 3,097.42% | 69.20% |
| Total Current Liabilities | 32.48% | 52.70% | -42.19% | 227.24% | 69.97% |
|
|
|||||
| Total Current Liabilities | 32.48% | 52.70% | -42.19% | 227.24% | 69.97% |
| Long-Term Debt | 7.08% | 88.12% | 0.27% | 146.54% | 0.36% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -14.99% | -8.01% | -8.73% | -7.86% | -9.63% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | 5.90% | -- | -- |
| Total Liabilities | 11.00% | 7.30% | -5.46% | 309.48% | 10.34% |
|
|
|||||
| Common Stock & APIC | 4.94% | 16.38% | 0.76% | 2.19% | 0.22% |
| Retained Earnings | -2.91% | -6.42% | -8.89% | -17.11% | -6.68% |
| Treasury Stock & Other | 4.11% | -15.31% | 6.46% | 1.34% | 3.84% |
| Total Common Equity | 10.77% | 56.76% | -22.45% | -25.21% | -9.75% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 10.77% | 56.76% | -22.45% | -25.21% | -9.75% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 10.77% | 56.76% | -22.45% | -25.21% | -9.75% |
|
|
|||||